Behavioral profile of a potent new psychotoxic compound.
D000328:Adult; D001259:Ataxia / Q000139:chemically induced; D001307:Auditory Perception / Q000187:drug effects; D001763:Blepharoptosis / Q000139:chemically induced; D003072:Cognition Disorders / Q000139:chemically induced; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D009019:Morphinans / Q000009:adverse effects / Q000633:toxicity*; D013064:Speech Disorders / Q000139:chemically induced; D013375:Substance Withdrawal Syndrome; D013797:Thebaine / Q000009:adverse effects / Q000633:toxicity; D014012:Tinnitus / Q000139:chemically induced; D014796:Visual Perception / Q000187:drug effects
D009019:Morphinans; D013797:Thebaine